What Are the Behavioral Symptoms of Childhood DM1?
At a Glance
In childhood-onset myotonic dystrophy type 1 (DM1), learning delays, ADHD-like traits, profound apathy, and excessive daytime sleepiness are often the first signs of the condition. Because the disease directly impacts the brain, children require regular neuropsychological evaluations and an individualized education program (IEP) with accommodations for severe fatigue.
In childhood-onset myotonic dystrophy type 1 (DM1), behavioral, cognitive, and learning challenges are often the very first signs of the condition, appearing long before any noticeable physical weakness [1][2]. The underlying brain changes caused by DM1 can affect how a child learns, processes information, and interacts with the world [3][4]. If your child has DM1, the hallmark signs you should watch for include extreme daytime sleepiness, profound apathy, traits that resemble ADHD or autism, and significant learning delays [3][5][6]. Because these early symptoms are invisible and behavioral, they are frequently misunderstood by teachers and peers, making early evaluation and school support absolutely essential [1][7].
Hallmark Cognitive and Behavioral Signs
The brain is heavily impacted in childhood-onset DM1 due to changes in the brain’s white matter (the network that connects different brain regions) [3]. This leads to a specific profile of behavioral and learning challenges:
- Learning Disabilities and Slower Development: Up to 90% of children with early-onset DM1 experience learning difficulties [8]. While children generally do not lose skills they have already learned, their pace of development is notably slower than their peers [9][10]. Over time, this can cause a widening academic gap.
- Executive Dysfunction: Children often struggle with executive function—the brain’s ability to plan, organize, pay attention, and switch between tasks [3][11]. This can look like being easily distracted, having trouble starting homework, or struggling with multi-step directions.
- ADHD and Autism Spectrum Traits: Symptoms mimicking Attention-Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD) are highly common [12][13]. This includes social communication difficulties, trouble reading social cues, and impulsivity [12][5]. It is important for clinicians to distinguish between DM1-specific brain changes and standalone autism [12].
- Profound Apathy: One of the most misunderstood symptoms is apathy, or a severe lack of motivation and initiative [3][14]. In DM1, apathy is a direct result of the disease’s effect on the brain, not a sign of laziness, stubbornness, or even depression [3][4].
- Excessive Daytime Sleepiness (EDS): Hypersomnolence, or excessive sleepiness during the day, is a major symptom that drastically impacts behavior and learning [6][3]. It is often tied to dysregulation in sleep patterns, meaning the brain does not get restorative rest even after a full night’s sleep [15]. This sleepiness can worsen behavioral outbursts and shorten a child’s attention span [6].
Securing Support for Your Child
Because childhood DM1 is multisystemic—affecting the brain as much as the body—proactive management is critical [5][16].
1. Request Regular Neuropsychological Evaluations
Routine neuropsychological screening is highly recommended for all children with suspected or confirmed DM1 [7][11]. This specialized testing goes beyond a standard IQ test to map exactly how your child’s brain processes information, identifying their specific strengths and deficits. Because DM1 is a progressive condition, this should not be a one-time event; evaluations should be repeated periodically to ensure school support adapts to your child’s changing needs [7].
2. Develop an Individualized Education Program (IEP)
Children with DM1 need an IEP tailored to their unique neurocognitive profile [5][16]. Because of severe fatigue and EDS, school accommodations should focus heavily on mitigating energy depletion [13]. An effective IEP might include:
- Shortened school days or scheduled rest periods
- Extra time for tests and assignments due to slower processing speeds
- Speech, physical, and occupational therapy integrated into the school week [16][17]
- Social skills training to help navigate autism-like traits
3. Coordinate with a Multidisciplinary Care Team
While there is no cure for DM1, some of the behavioral and cognitive symptoms can be managed with the help of specialized doctors, such as a pediatric neurologist, a sleep medicine specialist, and a cardiologist [16][18].
- Medication and Therapy: Medications like methylphenidate (often used for ADHD) have been studied to help address cognitive deficits, daytime sleepiness, and learning difficulties in children with DM1 [13]. Cognitive Behavioral Therapy (CBT) or psychological counseling can also help improve social participation and manage fatigue [19].
- Important Safety Note on Stimulants: Before considering any stimulant medication for ADHD symptoms or sleepiness, your child must have a thorough cardiac evaluation (such as an ECG) and ongoing monitoring [18][20]. DM1 carries a high risk of heart arrhythmias, and stimulants can affect heart rate and blood pressure. Always coordinate medication decisions with a cardiologist familiar with DM1.
Common questions in this guide
Why does my child with DM1 seem so unmotivated or apathetic?
How does excessive daytime sleepiness affect a child with DM1?
What school accommodations help children with DM1?
Can stimulant medications be used for ADHD symptoms in DM1?
Questions for Your Doctor
4 questions
- •Given my child's extreme daytime sleepiness, would a sleep study be appropriate to see if we can improve their rest?
- •What specific specialists—such as a pediatric neurologist or sleep medicine doctor—should be added to our care team to manage these behavioral symptoms?
- •If we are considering medication for ADHD symptoms or sleepiness, what cardiac screening is required first?
- •Can you provide a letter detailing the neurological basis of my child's apathy and fatigue to share with their school for the IEP process?
Questions for You
3 questions
- •What specific behavioral changes, such as 'zoning out' or extreme lack of motivation, have I noticed that teachers might be misinterpreting as laziness?
- •Have I observed any patterns around my child's sleepiness, such as specific times of day they struggle most or how it impacts their mood?
- •What are the most pressing daily challenges for my child right now—is it keeping up academically, social interactions, or simply staying awake during school?
Related questions
References
References (20)
- 1
Intellectual disability in paediatric patients with genetic muscle diseases.
Specht S, Straub V
Neuromuscular disorders : NMD 2021; (31(10)):988-997 doi:10.1016/j.nmd.2021.08.012.
PMID: 34736636 - 2
PREPUBERTAL GYNECOMASTIA: A RARE MANIFESTATION OF MYOTONIC DYSTROPHY TYPE 1.
Miranda PSF, Pereira EPMN, Barreto JSCB, et al.
Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo 2020; (38()):e2018294 doi:10.1590/1984-0462/2020/38/2018294.
PMID: 32074227 - 3
Cognitive Deficits, Apathy, and Hypersomnolence Represent the Core Brain Symptoms of Adult-Onset Myotonic Dystrophy Type 1.
Miller JN, Kruger A, Moser DJ, et al.
Frontiers in neurology 2021; (12()):700796 doi:10.3389/fneur.2021.700796.
PMID: 34276551 - 4
Characterization of Iron Accumulation in Deep Gray Matter in Myotonic Dystrophy Type 1 and 2 Using Quantitative Susceptibility Mapping and R2* Relaxometry: A Magnetic Resonance Imaging Study at 3 Tesla.
Ates S, Deistung A, Schneider R, et al.
Frontiers in neurology 2019; (10()):1320 doi:10.3389/fneur.2019.01320.
PMID: 31920940 - 5
Clinical features, quality of life, and fatigue in children with myotonic dystrophy type 1: A cross-sectional study.
Bektaş Öntaş H, Ardıçlı D, Eroğlu Ertuğrul NG, Çıtak Kurt AN
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2025; (60()):24-31 doi:10.1016/j.ejpn.2025.11.002.
PMID: 41240414 - 6
Association between Reported Sleep Disorders and Behavioral Issues in Children with Myotonic Dystrophy Type 1-Results from a Retrospective Analysis in Italy.
Trucco F, Lizio A, Roma E, et al.
Journal of clinical medicine 2024; (13(18)) doi:10.3390/jcm13185459.
PMID: 39336946 - 7
Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy.
Callus E, Bertoldo EG, Beretta M, et al.
Frontiers in neurology 2018; (9()):751 doi:10.3389/fneur.2018.00751.
PMID: 30298045 - 8
Parental diagnostic delay and developmental outcomes in congenital and childhood-onset myotonic dystrophy type 1.
Trucco F, Albamonte E, Pane M, et al.
Developmental medicine and child neurology 2025; (67(3)):365-373 doi:10.1111/dmcn.16079.
PMID: 39231278 - 9
Cognitive and adaptive functioning in congenital and childhood forms of myotonic dystrophy type 1: a longitudinal study.
Lindeblad G, Kroksmark AK, Ekström AB
Developmental medicine and child neurology 2019; (61(10)):1214-1220 doi:10.1111/dmcn.14161.
PMID: 30706460 - 10
Myotonic dystrophy type 1: clinical manifestations in children and adolescents.
Ho G, Carey KA, Cardamone M, Farrar MA
Archives of disease in childhood 2019; (104(1)):48-52 doi:10.1136/archdischild-2018-314837.
PMID: 29871899 - 11
Look at the cognitive deficits in patients with myotonic dystrophy type 1: an exploratory research on the effects of virtual reality.
Maresca G, Portaro S, Naro A, et al.
International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation 2020; (43(1)):90-94 doi:10.1097/MRR.0000000000000384.
PMID: 31851022 - 12
Childhood-onset form of myotonic dystrophy type 1 and autism spectrum disorder: Is there comorbidity?
Angeard N, Huerta E, Jacquette A, et al.
Neuromuscular disorders : NMD 2018; (28(3)):216-221 doi:10.1016/j.nmd.2017.12.006.
PMID: 29361396 - 13
Efficacy of methylphenidate treatment in childhood myotonic dystrophy type 1 and comorbid attention deficit hyperactivity disorder: A case report using eye tracking assessment.
Sweere DJJ, Hendriksen JGM, Jeroen Vermeulen R, Klinkenberg S
Brain & development 2024; (46(2)):118-121 doi:10.1016/j.braindev.2023.11.004.
PMID: 38007339 - 14
Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
Van Heugten C, Meuleman S, Hellebrekers D, et al.
Journal of neuromuscular diseases 2018; (5(2)):205-214 doi:10.3233/JND-170246.
PMID: 29865086 - 15
Disruption of sleep-wake continuum in myotonic dystrophy type 1: Beyond conventional sleep staging.
Bonanni E, Carnicelli L, Crapanzano D, et al.
Neuromuscular disorders : NMD 2018; (28(5)):414-421 doi:10.1016/j.nmd.2018.02.004.
PMID: 29631952 - 16
Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1.
Johnson NE, Aldana EZ, Angeard N, et al.
Neurology. Clinical practice 2019; (9(5)):443-454 doi:10.1212/CPJ.0000000000000646.
PMID: 31750030 - 17
A Greek National Cross-Sectional Study on Myotonic Dystrophies.
Papadimas GK, Papadopoulos C, Kekou K, et al.
International journal of molecular sciences 2022; (23(24)) doi:10.3390/ijms232415507.
PMID: 36555146 - 18
Impact of gastrointestinal and urological symptoms in children with myotonic dystrophy type 1.
Maagdenberg SJM, Klinkenberg S, Sophie van den Berg J, et al.
Neuromuscular disorders : NMD 2024; (35()):1-7 doi:10.1016/j.nmd.2023.12.011.
PMID: 38184901 - 19
Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial.
Okkersen K, Jimenez-Moreno C, Wenninger S, et al.
The Lancet. Neurology 2018; (17(8)):671-680 doi:10.1016/S1474-4422(18)30203-5.
PMID: 29934199 - 20
Myotonic Dystrophy.
Perez PG
Continuum (Minneapolis, Minn.) 2025; (31(5)):1437-1461 doi:10.1212/cont.0000000000001621.
PMID: 41037177
This page provides educational information about behavioral and cognitive symptoms in childhood DM1. Always consult your pediatric neurologist or care team for specific medical advice and before starting any new medications.
Get notified when new evidence is published on Steinert myotonic dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.